Cohen Yuval

Average Profitability
10.48%
Insider Buys Quantity
25
Insider Buys Sum
$149,114.53
Insider Sells Quantity
3
Insider Sells Sum
$1.11M

Insider Activity of Cohen Yuval

According to the SEC Form 4 filings, Cohen Yuval, being in a position of

  1. Chief Executive Officer at Corbus Pharmaceuticals Holdings, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 23758 shares for $1.11M,
    over all time since 2014-12-03, has bought 57200 shares for $149,115, and sold 23758 shares for $1.11M.

The largest purchase of all time was on 2017-05-11 and amounted to 3250 shares of Corbus Pharmaceuticals Holdings, Inc. for $19,539.

The largest sale of all time was on 2024-06-14 and amounted to 12487 shares of Corbus Pharmaceuticals Holdings, Inc. for $626,425.

Biography of Cohen Yuval

No biography is available at this moment.

2024-06-18SaleCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
9,501
0.1849%
$42.24$401,294-3.04%
2024-06-17SaleCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
1,770
0.0375%
$46.02$81,456-3.7%
2024-06-14SaleCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
12,487
0.2886%
$50.17$626,425-14.83%
2022-08-10PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
3,800
0.0005%
$0.26$1,003-23.53%
2022-05-16PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
10,500
0.0012%
$0.25$2,625-34.56%
2022-03-09PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
8,600
0.0015%
$0.37$3,182-44.14%
2020-11-11PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
4,240
0.0024%
$1.21$5,126+24.59%
2020-03-17PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
4,300
0.0069%
$3.49$15,007-30.88%
2019-11-12PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
1,430
0.0028%
$4.26$6,092+33.95%
2019-08-12PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
1,175
0.0033%
$6.06$7,116-6%
2019-05-13PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
995
0.0032%
$6.99$6,955-20.56%
2019-03-14PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
1,530
0.0046%
$6.49$9,930-14.71%
2018-05-15PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
1,725
0.0046%
$5.85$10,091+5.24%
2018-03-14PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
1,160
0.0037%
$6.88$7,987-8.82%
2017-11-10PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
1,000
0.0033%
$7.17$7,169-8.97%
2017-08-11PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
1,695
0.0047%
$6.00$10,170+9.24%
2017-05-11PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
3,250
0.009%
$6.01$19,539+10.57%
2016-11-22PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
1,340
0.0047%
$7.64$10,238-13.21%
2016-06-06PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
1,500
0.0023%
$3.34$5,010+106.4%
2016-05-18PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
2,125
0.0023%
$2.40$5,100+180.21%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.